Share on StockTwits

Heska (NASDAQ:HSKA) Director Robert B. Grieve sold 12,000 shares of the company’s stock on the open market in a transaction dated Monday, August 4th. The shares were sold at an average price of $13.57, for a total transaction of $162,840.00. Following the sale, the director now directly owns 130,315 shares in the company, valued at approximately $1,768,375. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of Heska (NASDAQ:HSKA) traded up 2.06% during mid-day trading on Tuesday, hitting $14.135. 82,942 shares of the company’s stock traded hands. Heska has a one year low of $5.16 and a one year high of $13.90. The stock has a 50-day moving average of $11.31 and a 200-day moving average of $10.49. The company has a market cap of $83.9 million and a P/E ratio of 31.55.

Heska (NASDAQ:HSKA) last announced its earnings results on Wednesday, July 30th. The company reported $0.17 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.03) by $0.20. On average, analysts predict that Heska will post $0.40 earnings per share for the current fiscal year.

HSKA has been the subject of a number of recent research reports. Analysts at Zacks upgraded shares of Heska from a “neutral” rating to an “outperform” rating in a research note on Tuesday, July 8th. They now have a $13.30 price target on the stock. Analysts at Raymond James reiterated an “outperform” rating on shares of Heska in a research note on Friday, May 9th. They now have a $13.00 price target on the stock, up previously from $12.50.

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.